Oral bioactive peptides can induce T-regulatory cell-mediated tolerance that improves allergy, arthritis, and colitis, but higher T-reg levels are associated with increased solid cancer risk.
Double-edged swordT-reg expansion from bioactive peptides benefits autoimmune conditions but may increase solid cancer risk
What the researchers found
Oral bioactive peptides improve multiple diseases via T-reg expansion, and collagen hydrolysate supplementation reduces OA pain. However, higher circulating T-regs are associated with reduced CVD/allergy risk but increased solid cancer risk.
Why it matters
As collagen peptide and bioactive peptide supplements grow in popularity, understanding their immune effects — both beneficial and potentially harmful — is critical for safe long-term use recommendations.
The numbers in context
3,081 papers identified; collagen induces T-reg oral tolerance; benefits for OA established; theoretical immune concerns raised.
How the study worked
Systematic review searching PubMed and Scopus. 3081 papers identified, 22 included: 12 on BP-induced oral tolerance, 6 on collagen hydrolysate for OA, and 4 observational studies on T-regs and chronic disease risk.
Who was studied
Systematic review of bioactive peptide oral tolerance, collagen in OA, and T-reg biology
What this study cannot tell us
Systematic review but with heterogeneous study designs and mostly animal data for tolerance induction. Cancer risk association is observational and causation isn't established. T-reg subtypes and their specific roles weren't distinguished.
How to read the evidence
Systematic review with 22 included studies. Animal evidence for tolerance is strong; human cancer risk association is observational. The connection between supplement-induced T-regs and cancer needs further study.
When this study was published
Published in 2021. The immune effects of long-term peptide supplementation remain an important but understudied area.
The bigger picture
The immune modulation induced by dietary bioactive peptides represents both an opportunity and a caution. While T-reg-mediated tolerance can treat autoimmune and inflammatory conditions, the same immune suppression could theoretically impair cancer surveillance.
Questions still open
- Should long-term collagen peptide supplementation be monitored for cancer risk?
- Can the beneficial T-reg tolerance be achieved without cancer-promoting immune suppression?
- Do different bioactive peptide sources induce different T-reg profiles with different risk/benefit ratios?
Common questions
Can collagen supplements affect the immune system?
Should I stop taking collagen supplements?
Read the original research
Regulatory T Cells in Bioactive Peptides-Induced Oral Tolerance; a Two-Edged Sword Related to the Risk of Chronic Diseases: A Systematic Review.
Nutrition and cancer, 73(6), 956-967
Citation
Barati, Meisam; Jabbari, Masoumeh; Nickho, Hamid; Esparvarinha, Mojgan; Javadi Mamaghani, Amirreza; Majdi, Hasan; Fathollahi, Anwar; Davoodi, Sayed Hossein. (2021). Regulatory T Cells in Bioactive Peptides-Induced Oral Tolerance; a Two-Edged Sword Related to the Risk of Chronic Diseases: A Systematic Review.. Nutrition and cancer, 73(6), 956-967. https://doi.org/10.1080/01635581.2020.1784442